Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs

por Sugarman, Jeremy, Stalter, Randy, Bokoch, Kevin, Liu, Ting-Yuan, Donnell, Deborah
Publicado en IRB (2015)

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

por Mitchell, Kate M., Dimitrov, Dobromir, Hughes, James P., Xia, Fan, Donnell, Deborah, Amico, K. Rivet, Bokoch, Kevin, Chitwarakorn, Anupong, Bekker, Linda-Gail, Holtz, Timothy H., Mannheimer, Sharon, Grant, Robert M., Boily, Marie-Claude
Publicado en AIDS (2018)

Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067

por Figueroa, Dominique B., Tillotson, Joseph, Li, Maoji, Piwowar-Manning, Estelle, Hendrix, Craig W., Holtz, Timothy H., Bokoch, Kevin, Bekker, Linda-Gail, van Griensven, Frits, Mannheimer, Sharon, Hughes, James P., Grant, Robert M., Bumpus, Namandjé N.
Publicado en PLoS One (2018)

Characterization of HIV seroconverters in a TDF/FTC PrEP study: HPTN 067/ADAPT

por Sivay, Mariya V., Li, Maoji, Piwowar-Manning, Estelle, Zhang, Yinfeng, Hudelson, Sarah E., Marzinke, Mark A., Amico, Rivet K., Redd, Andrew, Hendrix, Craig W., Anderson, Peter L., Bokoch, Kevin, Bekker, Linda-Gail, van Griensven, Frits, Mannheimer, Sharon, Hughes, James P., Grant, Robert, Eshleman, Susan H.
Publicado en J Acquir Immune Defic Syndr (2017)